title: Presenilin-1 protein expression in familial and sporadic Alzheimer's disease.
abstract: Mutations of the presenilin PS1 and PS2 genes are closely linked to aggressive forms of early-onset (< 60 years) familial Alzheimer's disease. A highly specific monoclonal antibody was developed to identify and characterize the native PS1 protein. Western blot analyses revealed a predominant 32-kd immunoreactive polypeptide in a variety of samples, including PC12 cells transfected with human PS1 complementary DNA, brain biopsy specimens from demented patients, and postmortem samples of frontal neocortex from early-onset familial Alzheimer's disease cases (PS1 and PS2), late-onset sporadic Alzheimer's disease cases, and cases of other degenerative disorders. This truncated polypeptide contains the N-terminus of PS1 and appeared unchanged across cases. In 2 early-onset cases linked to missense mutations in the PS1 gene, a PS1 immunoreactive protein (approximately 49 kd) accumulated in the frontal cortex. This protein was similar in size to full-length PS1 protein present in transfected cells overexpressing PS1 complementary DNA, and in lymphocytes from an affected individual with a deletion of exon 9 of the PS1 gene, suggesting that mutations of the PS1 gene peturb the endoproteolytic processing of the protein. Immunohistochemical studies of control brains revealed that PS1 is expressed primarily in neurons, with the protein localized in the soma and dendritic processes. In contrast, PS1 showed striking localization to the neuropathology in early-onset familial Alzheimer's disease and sporadic Alzheimers' disease cases. PS1 immunoreactivity was present in the neuritic component of senile plaques as well as in neurofibrillary tangles. Localization of PS1 immunoreactivity in familial and sporadic Alzheimer's disease suggests that genetically heterogeneous forms of the disease share a common pathophysiology involving PS1 protein.
authors.affiliation: Department of Neurology, Emory University School of Medicine, Atlanta, GA 30322, USA.
authors.forename: A I
authors.initials: AI
authors.lastname: Levey
authors.forename: C J
authors.initials: CJ
authors.lastname: Heilman
authors.forename: J J
authors.initials: JJ
authors.lastname: Lah
authors.forename: N R
authors.initials: NR
authors.lastname: Nash
authors.forename: H D
authors.initials: HD
authors.lastname: Rees
authors.forename: M
authors.initials: M
authors.lastname: Wakai
authors.forename: S S
authors.initials: SS
authors.lastname: Mirra
authors.forename: D B
authors.initials: DB
authors.lastname: Rye
authors.forename: D
authors.initials: D
authors.lastname: Nochlin
authors.forename: T D
authors.initials: TD
authors.lastname: Bird
authors.forename: E J
authors.initials: EJ
authors.lastname: Mufson
mesh_terms: D000328:Adult; D000368:Aged; D000544:Alzheimer Disease / Q000235:genetics* / Q000378:metabolism*; D000818:Animals; D015153:Blotting, Western; D001921:Brain / Q000378:metabolism; D000882:Haplorhini; D006801:Humans; D007150:Immunohistochemistry; D008565:Membrane Proteins / Q000378:metabolism*; D008875:Middle Aged; D016716:PC12 Cells / Q000378:metabolism; D053764:Presenilin-1; D051381:Rats; D014018:Tissue Distribution; D014162:Transfection
chemical_list: D008565:Membrane Proteins; C508853:PSEN1 protein, human; D053764:Presenilin-1